SCHEDULE: Viking Global Updates Ginkgo Bioworks Stake
Schedule 13G Amendment
Viking Global Investors filed an amended Schedule 13G to reflect the retirement of David C. Ott from its reporting group regarding Ginkgo Bioworks.
Summary
- Viking Global Investors LP and associated entities report beneficial ownership of 3,577,128 shares of Ginkgo Bioworks Holdings, Inc. Class A Common Stock.
- This represents a 7.1% ownership stake in the company.
- The filing serves as an amendment to remove David C. Ott from the list of reporting persons following his retirement effective March 31, 2026.
- The reported shares include 2,900,025 directly owned shares and 677,103 shares subject to potential forfeiture based on price targets.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral administrative filing reflecting a change in personnel at the investment firm rather than a change in the underlying investment strategy.
Positives
- The filing confirms the continued significant institutional investment of 7.1% by Viking Global in Ginkgo Bioworks.
Negatives
- The reporting group has decreased in size due to the retirement of a key executive, David C. Ott.
Risks
- A portion of the beneficially owned shares (677,103) remains subject to forfeiture if specific price targets are not met.
Future Outlook
The filing does not provide forward-looking business guidance for Ginkgo Bioworks, as it is a regulatory disclosure of ownership status.
Industry Context
StockSavvy.ai notes that institutional ownership filings like this are standard regulatory updates and do not typically signal a change in investment thesis, but rather reflect internal administrative changes within the investment firm.
Comparison to Industry Standards
- The filing adheres to standard SEC requirements for Schedule 13G amendments regarding changes in reporting persons.
- The 7.1% stake is consistent with typical institutional holding patterns for mid-cap biotechnology firms.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Advisory Director of VGI / Executive Committee Member | David C. Ott | None | 03/31/2026 | Retirement |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Reporting Group Composition | Removal of David C. Ott from the Schedule 13G reporting group. | 03/31/2026 | Minimal; administrative change due to retirement. |
Stakeholder Impact
- Shareholders should note the change in the reporting group, though the total beneficial ownership remains unchanged.
Next Steps
- Continued monitoring of future 13G or 13F filings for changes in Viking Global's position.
Key Dates
| Date | Description |
|---|---|
| 02/09/2021 | Date of authorization and designation letter for signatory. |
| 03/31/2026 | Effective date of David C. Ott's retirement. |
| 05/07/2026 | Date of Issuer's quarterly report on Form 10-Q used for share count reference. |
| 05/15/2026 | Date of filing and execution of the Joint Filing Agreement. |
Keywords
Ginkgo Bioworks, Viking Global Investors, Schedule 13G, Institutional Ownership, Biotechnology, Equity Disclosure
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.